Proton-mediated liberation of aldophosphamide from a nontoxic prodrug: a strategy for tumor-selective activation of cytocidal drugs

Based on the findings that the pH in malignant tumors can be preferentially decreased by stimulation of their aerobic glycolysis, acid-sensible prodrugs, which are nearly nontoxic at physiological pH, were synthesized. At lower pH, however, these compounds are cleaved with liberation of a cytotoxic...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 49; no. 15; pp. 4179 - 4184
Main Authors TIETZE, L. F, NEUMANN, M, MÖLLERS, T, FISCHER, R, GLÜSENKAMP, K.-H, RAJEWSKY, M. F, JÄHDE, E
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 01.08.1989
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Based on the findings that the pH in malignant tumors can be preferentially decreased by stimulation of their aerobic glycolysis, acid-sensible prodrugs, which are nearly nontoxic at physiological pH, were synthesized. At lower pH, however, these compounds are cleaved with liberation of a cytotoxic species. The prototypic drug compound 2-hexenopyranoside of aldophosphamide was prepared, which releases aldophosphamide by acid-catalyzed hydrolysis. Exposure of cultured M1R rat mammary carcinoma cells to this agent at pH 7.4 only resulted in slight toxicity. However, when drug treatment was performed at pH 6.2, the mean pH in malignant tumors of hyperglycemic hosts, the colony-forming fraction of M1R cells decreased to 0.05 and 0.0001 of controls treated at pH 7.4 after exposure for 24 h and 48 h, respectively. The synthesis of the 2-hexenopyranoside of aldophosphamide is described in detail.
ISSN:0008-5472
1538-7445